Introduction
Exposure to allergens early in life may have an impact on the incidence of allergy many years later (1) (2) (3) . The initial exposures to ubiquitous allergens invariably occur during the first year of life, or even before birth (4) . In support of an important role for the gestational environment on offspring immune development, maternal exposure to stables during pregnancy protects against allergic sensitisation, whereas exposures during infancy has weaker or no effect at all (5) . The priming and the status of the immune system before and at birth and its relation to subsequent allergic disease needs further investigation, however.
During pregnancy, the fetomaternal interface is surrounded by high levels of T helper (Th)2-like cytokines (6) , probably in order to divert the maternal immune response away from damaging Th1-mediated immune responses (7) . This Th2 polarisation during pregnancy may influence the offspring for variable periods postnatally. As the cytokine milieu at the priming of T cells direct the Th1/Th2 differentiation (8) , the gestational environment could be very important for shaping immune responses. Maternal sensitisation to allergens was associated with a decreased ability to produce the Th2 antagonist IFN-γ in newborn mice (9) and an elevated production of the Th2-like cytokine IL-13 in the human infant (10) . The higher cord blood (CB) IgE levels seen in newborns of allergic mothers as compared to newborns with a paternal or no allergic history (11) (12) (13) may depend on a stronger decidual Th2 shift in allergic mothers (14) .
In addition to the Th2-dominated cytokine profile, an upregulation of Th2-induced chemokines has been associated with allergic manifestations including atopic dermatitis (15) (16) (17) and asthma (18) (19) (20) . The chemokines comprise a large protein family, which is responsible for the trafficking of leukocytes to the site of inflammation and the regulation of leukocyte maturation (21) . The chemokine receptors are expressed on the surface of several cell types involved in the allergic inflammation, e. g. eosinophils, monocytes, Th1 and Th2 lymphocytes (22) . Atopic dermatitis is associated with high circulating levels of Th2-associated eotaxin (CC ligand 11 (CCL11) (16) , macrophage-derived chemokine (MDC (CCL22)) (15, 16, 23) , thymus-and activation-regulated chemokine (TARC (CCL17)) (15) (16) (17) and pulmonary and activation regulated chemokine (PARC (CCL18) (24) in children and adults. Increased levels of MDC (CCL22) and TARC (CCL17) in bronchoalveolar lavage fluid (BALF) have been reported in asthmatics (18) after allergen challenge (20) . In contrast, interferon-γ inducible protein 10 (IP-10 (CXCL10)) and interferon-γ inducible T cell α chemoattractant (I-TAC (CXCL11)) are associated with Th1-like diseases like sarcoidosis, tuberculosis (19) and Crohn´s disease (25) .
Chemokines have a crucial role in establishing the Th1/Th2 balance and they are widely used as markers for Th1/Th2 immunity. The relation between the occurrence of CB chemokines at birth and the development of allergic diseases in the offspring is poorly understood. We hypothesize that maternal allergy is associated with increased levels of cord blood IgE antibodies, an elevated production of Th2-like cyto-and chemokines and development of allergic diseases in the child. To address our hypothesis, 20 allergic pregnant women and 36 non-allergic pregnant women were recruited, and their children were followed to 2 years of age. Using a multiplexed Luminex assay and sensitive ELISA, CB concentrations of the cytokines interleukin-4 (IL-4), IL-5, IL-9, IL-10, IL-12(p70), IL-13, IFN-γ and the chemokines eotaxin (CCL11), IP-10 (CXCL10), I-TAC (CXCL11), MDC (CCL22), TARC (CCL17), PARC (CCL18) were quantified and related to maternal IgE levels during pregnancy.
Methods

Study group
The study comprised 20 allergic (mean age (range) 30.8 years (24-38), mean number of previous successful pregnancies 0.55 (0-2)) and 36 non-allergic (mean age (range) 30.8 years (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) , mean number of previous successful pregnancies 0.81 (0-2)) pregnant women from the Linköping area, County of Östergötland, Sweden. Due to technical and practical reasons, it was not possible to perform this study with a larger number of participants.
The allergic status was established by a typical clinical history, e.g. allergic rhinoconjuntivitis (ARC, n=17), allergic asthma (n=4 of whom 1 also had ARC) or flexural itchy eczema (n=2, both had also ARC). An experienced allergy research nurse interviewed the women using Eczema was defined as pruritic, chronic or chronically relapsing non-infectious dermatitis with typical features and distribution. Asthma was defined as three or more episodes of bronchial obstruction, at least once verified by a physician or two episodes of bronchial obstruction combined with eczema or food allergy. In this cohort, all sensitised children with bronchial obstruction episodes had wheezed more than three times, however.
Allergic rhino-conjunctivitis was defined as rhinitis and conjunctivitis appearing at least twice after exposure to a particular allergen and not related to infection. Urticaria was defined as allergic if it appeared at least twice within one hour after exposure to a particular allergen.
Food-related gastrointestinal problems were defined as vomiting and/or diarrhoea on at least two separate occasions after intake of certain offending food. Thirteen children reported allergic symptoms. Ten children had eczema and 4 of them also had asthma. Of the 5 children with asthma, 3 also had eczema, 1 also had urticaria, and 1 child had both eczema and urticaria combined with asthma. Three children fulfilled some, but not all criteria for allergic disease and 34 showed no symptoms of allergic disease (Fig 1) .
Skin prick tests (SPT) were performed in duplicate on the volar aspects of the forearms. The allergens used were; thawed egg white, fresh skimmed cow´s milk (lipid concentration 0.5%) (6, 12 and 24 months), cat (12 and 24 months), and birch and timothy (24 months). If a pet is present at home and if the parents wanted to know if their child was sensitised to that species, an additional allergen was used i.e. cat, dog, horse, bird, and rodent. All extracts were standardised allergen extracts from ALK (Soluprick®, ALK, Hørsholm, Denmark). Histamine hydrochloride (10 mg/ml) was used as positive control and glycerol as negative control. The test was regarded as positive when the mean wheal diameter was at least 3 mm. Thirteen of the children had at least 1 positive SPT, 11 to egg, 3 to milk, 2 to cat, 1 to dog and 1 to timothy. Forty children were not sensitised. Eight of the children with allergic symptoms were SPT positive. Five of these children had eczema, 2 of them also had asthma and 1 child had urticaria and asthma. Thirty children were non-sensitised without allergic symptoms.
Determination of total IgE
The total IgE concentrations in the 46 CB samples were analysed by the immunoassay system ImmunoCAP (Pharmacia Diagnostics, Uppsala, Sweden) using ImmunoCAP Total IgE Low
Range to allow detection of very low IgE concentrations. The procedure recommendations were followed and the results were expressed as kU/l.
CB cytokine and chemokine concentrations determined by a multiplexed Luminex assay
The concentrations of IL-4, IL-5, IL-9, IL-10, IL-12(p70), IL-13, IFN-γ, eotaxin (CCL11), IP-10 (CXCL10) and MDC (CCL22) in the CB samples were obtained by a multiplex assay using Beadlyte ® Human Multi-Cytokine Beadmaster™ Kit (Upstate, CA, USA) according to the manufacturer's instructions. Both CB serum and plasma were analysed with this kit, as the manufacturer stated that this was appropriate. The majority of the CB samples were plasma samples.
Briefly, the CB samples were diluted 1:2 in serum diluent and mixed with a mixture of anticytokine/chemokine mouse monoclonal antibodies coupled to different Luminex® beads (Beadlyte® Anti-Cytokine beads, Upstate, CA, USA). A 7-point standard curve with 3-fold dilutions was used to achieve low-end sensitivity. To increase the overall sensitivity, the plate was incubated over night at 4°. After washing, a Beadlyte® anti-cytokine biotinylated reporter (Upstate, CA, USA) was added to the beads and incubated at room temperature (RT). pg/ml for I-TAC (CXCL11) and 8 pg/ml for TARC (CCL17) and PARC (CCL18). The CV between the duplicates was below 15% and the mean CV for all samples were 4 %.
Statistics
Non-parametric tests, corrected for ties, were used. The correlations were analysed with Spearman's rank order correlation coefficient test and comparisons between unpaired groups with Mann-Whitney U-test. The calculations were made with the statistical package SPSS 14.0 for Windows (SPSS Inc, Chicago, IL, USA). Undetectable samples were given the value of half the cut-off.
Ethics
The study was approved by the Regional Ethics Committee for Human Research at the University Hospital of Linköping.
Results
CB levels of cytokines and chemokines
A number of the analysed cytokines (IL-4, IL-5, IL-9, IL-10, IL-12(p70), IL-13, IFN-γ) were undetectable, or only sporadically detectable, in the CB samples, even though an overnight incubation of beads and samples was done to achieve higher sensitivity. In contrast, both Th1-and Th2-associated chemokines were readily detectable in umbilical CB. Among these chemokines, Th1-associated I-TAC (CXCL11) and IP-10 (CXCL10) correlated significantly with each other (Rho=0.37, p=0.01), with a similar tendency for Th2-associated MDC (CCL22) and TARC (CCL17) (Rho=0.26, p=0.09). Chemokine levels were similar in newborns of sensitised mothers with allergic symptoms (n=13) and non-sensitised mothers without allergic symptoms (n=30). The CB levels of chemokines and IgE antibodies were not influenced by other factors such as smoking during pregnancy (n=7), number of previous pregnancies and neonatal gender (Mann-Whitney U-test).
Correlations between CB chemokine and IgE levels
The levels of CB MDC (CCL22) correlated with CB IgE levels (Rho=0.37, p=0.01). 
Levels and ratios of CB chemokines and IgE are related to allergic disease in the offspring
Children with allergic symptoms (n=11) showed significantly higher TARC (CCL17) levels than children without allergic symptoms (n=27) ( Table 1) . Furthermore, the MDC (CCL22) / IP-10 (CXCL10) and TARC (CCL17) / IP-10 (CXCL10) ratios were higher (p=0.02 and p=0.01, respectively) in children with, as compared to without, allergic symptoms. IP-10, interferon-γ inducible protein 10; I-TAC, interferon-γ inducible T cell α chemoattractant; MDC, macrophage-derived chemokine; TARC, thymus-and activation-regulated chemokine; PARC, pulmonary and activation regulated chemokine.
Using more strict criteria for allergic disease, sensitised children with allergic symptoms during the first 2 years of life had significantly higher MDC (CCL22) levels at birth compared to non-sensitised children without allergic symptoms (Fig 3) . Moreover, the ratios of MDC (CCL22) to IP-10 (CXCL10) and I-TAC (CXCL11) were higher in the sensitised children with allergic symptoms (Fig 4) . Similar trends were shown for TARC (CCL17) / IP-10 (CXCL10) and TARC (CCL17) / I-TAC (CXCL11) ratios (p=0.07 and p=0.08, respectively). The chemokine levels were analysed using a multiplexed Luminex assay and the groups were compared using the Mann-Whitney U-test.
Figure 4. The CB ratios between (A) MDC (CCL22) / IP-10 (CXCL10) and (B) MDC (CCL22) / I-TAC (CXCL11) in 7 children who did develop allergic symptoms and sensitisation during the first 2 years of life and 25 children who did not develop allergic symptoms or sensitisation during the first 2 years of life. The chemokines were detected by a multiplexed Luminex assay and ELISA. The unpaired comparisons were performed using the Mann-Whitney U-test. The median is represented by a black line.
Three children in the group of sensitised children with allergic symptoms were diagnosed with asthma and eczema/urticaria. These children correspond to the highest MDC (CCL22)
concentrations and MDC (CCL22) / IP-10 (CXCL10) ratios within the group of sensitised children with allergic symptoms. Due to the small group size, this finding could not be verified with an appropriate statistical analysis.
The sensitised children with allergic symptoms, as compared to non-sensitised children without allergic symptoms, also had higher levels of CB IgE antibodies (median (range) 0.87 kU/l (0.17-1.46) and 0.17 kU/l (0.17-5.36), p=0.01 respectively). Although CB IgE and maternal IgE levels correlated, we did not observe higher CB IgE levels in newborns of sensitised mothers with allergic symptoms compared to non-sensitised mothers without allergic symptoms.
Discussion
In support of the idea of prenatal priming of the immune system, we found that the maternal In contrast, no differences in PARC (CCL18) levels or ratios were observed between the allergic and non-allergic children, although this Th2 associated chemokine has shown to be related to atopic dermatitis (29) . We observed much higher CB levels of PARC (CCL18) than of the other chemokines, however, possibly indicating a less strict regulation of this chemokine. Our inability to determine differences in CB PARC (CCL18) and eotaxin Similar to other studies, we found that high CB IgE levels were associated with allergic disease in the offspring (31, 32) . In addition, we found that the maternal IgE levels during pregnancy influence the CB IgE levels, since significant correlations occurred at gestational week 15, 39 and 12 months after delivery. This is in agreement with a previous report (12) and indicates that the maternal immunity during pregnancy does have an impact on the prenatal IgE synthesis.
In conclusion, we found that the maternal IgE levels during and after pregnancy correlated with CB MDC (CCL22) and IgE levels, suggesting that the gestational environment may be very important for shaping immune responses in the neonate. Development of sensitisation and allergic disease was associated with a more marked Th2-like deviation already at birth, shown as increased levels of CB IgE and MDC (CCL22), and higher ratios of MDC (CCL22)
to IP-10 (CXCL10) and I-TAC (CXCL11).
